Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 2
1971 2
1972 2
1973 2
1978 3
1979 1
1980 1
1981 2
1982 1
1983 2
1984 2
1985 1
1986 3
1987 2
1990 12
1991 7
1992 5
1993 8
1994 4
1995 5
1996 9
1997 13
1998 13
1999 15
2000 9
2001 13
2002 10
2003 16
2004 13
2005 16
2006 20
2007 12
2008 11
2009 17
2010 14
2011 26
2012 23
2013 13
2014 17
2015 21
2016 10
2017 10
2018 9
2019 18
2020 6
2021 12
2022 14
2023 25
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Results by year

Filters applied: . Clear all
Page 1
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.
Chen TW, Dai MS, Tseng LM, Chen SC, Chao TY, Chao TC, Chang YC, Chiu CF, Liu CT, Lin CH, Liu CY, Chen YF, Chang DY, Yu JC, Rau KM, Hsieh YY, Shen SC, Huang SM, Cheng AL, Lu YS. Chen TW, et al. Among authors: chao tc. JAMA Oncol. 2024 Mar 1;10(3):325-334. doi: 10.1001/jamaoncol.2023.5456. JAMA Oncol. 2024. PMID: 38127335 Clinical Trial.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Jun 20;42(18):2149-2160. doi: 10.1200/JCO.23.01500. Epub 2024 Mar 27. J Clin Oncol. 2024. PMID: 38537155 Free PMC article. Clinical Trial.
Genomic Alterations of Tumors in HER2-Low Breast Cancers.
Tsai YF, Huang CC, Hsu CY, Feng CJ, Lin YS, Chao TC, Lai JI, Lien PJ, Liu CY, Chiu JH, Tseng LM. Tsai YF, et al. Among authors: chao tc. Int J Mol Sci. 2024 Jan 21;25(2):1318. doi: 10.3390/ijms25021318. Int J Mol Sci. 2024. PMID: 38279318 Free PMC article.
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF, Tsai YF, Liu CY, Hsu CY, Lien PJ, Lin YS, Chao TC, Lai JI, Feng CJ, Chen YJ, Chen BF, Chiu JH, Tseng LM, Huang CC. Cheng HF, et al. Among authors: chao tc. Breast Cancer Res. 2023 Dec 14;25(1):152. doi: 10.1186/s13058-023-01751-z. Breast Cancer Res. 2023. PMID: 38098088 Free PMC article.
Legal medicine.
Chao TC. Chao TC. Ann Acad Med Singap. 1993 Jan;22(1):1. Ann Acad Med Singap. 1993. PMID: 8503626 No abstract available.
453 results